Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Prostate Cancer |
Free Subscription
2 Anticancer Res |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Manganese as a Possible Anticancer Enhancer in Docetaxel Treatment of Prostate
Cancer Cells.
Anticancer Res. 2024;44:953-962.
PubMed
Abstract available
Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand
Therapy in Prostate Cancer.
Anticancer Res. 2024;44:879-888.
PubMed
Abstract available
During the COVID-19 pandemic 20 000 prostate cancer diagnoses were missed in
England.
BJU Int. 2024 Feb 27. doi: 10.1111/bju.16305.
PubMed
Abstract available
Reply to 'Re: Prostate-specific membrane antigen positron emission tomography in
addition to multiparametric magnetic resonance imaging and biopsies to select
prostate cancer patients for focal therapy'.
BJU Int. 2024 Feb 28. doi: 10.1111/bju.16308.
PubMed
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes
(DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy
versus surveillance for low-risk biochemical recurrence after radical
prostatectomy.
BJU Int. 2024;133 Suppl 3:39-47.
PubMed
Abstract available
How prostate-specific membrane antigen positron emission tomography is refining
risk calculators in the primary prostate diagnostic pathway.
BJU Int. 2024;133 Suppl 3:13-14.
PubMed
Gut microbiota in patients with prostate cancer: a systematic review and
meta-analysis.
BMC Cancer. 2024;24:261.
PubMed
Abstract available
A nomogram based on peripheral lymphocyte for predicting 8-year survival in
patients with prostate cancer: a single-center study using LASSO-cox regression.
BMC Cancer. 2024;24:254.
PubMed
Abstract available
Capivasertib combines with docetaxel to enhance anti-tumour activity through
inhibition of AKT-mediated survival mechanisms in prostate cancer.
Br J Cancer. 2024 Feb 23. doi: 10.1038/s41416-024-02614.
PubMed
Abstract available
Geometric distortion caused by metallic femoral head prosthesis in prostate
cancer imaging on an MR linac: in-vivo measurements of spatial deformation.
Br J Radiol. 2024 Feb 24:tqae044. doi: 10.1093.
PubMed
Abstract available
Secondary analysis of late major gastrointestinal and genitourinary toxicities in
unfavorable-risk prostate cancer patients receiving docetaxel: Insights from a
randomized trial.
Cancer. 2024 Mar 1. doi: 10.1002/cncr.35274.
PubMed
Abstract available
The 340B Program and oral specialty drugs for advanced prostate cancer.
Cancer. 2024 Feb 23. doi: 10.1002/cncr.35262.
PubMed
Abstract available
Identification of a 9-gene signature to enhance biochemical recurrence prediction
in primary prostate cancer: A benchmarking study using ten machine learning
methods and twelve patient cohorts.
Cancer Lett. 2024 Feb 21:216739. doi: 10.1016/j.canlet.2024.216739.
PubMed
Abstract available
CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear
translocation to suppress prostate cancer metastasis.
Cancer Lett. 2024 Feb 27:216743. doi: 10.1016/j.canlet.2024.216743.
PubMed
Abstract available
Impact of Interfractional Bladder and Trigone Displacement and Deformation on
Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc
Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate
Stereotactic Body Rad
Int J Radiat Oncol Biol Phys. 2024;118:986-997.
PubMed
Abstract available
Understanding RBE and clinical outcome of prostate cancer therapy using particle
irradiation: analysis of tumor control probability with mMKM.
Int J Radiat Oncol Biol Phys. 2024 Feb 27:S0360-3016(24)00331.
PubMed
Abstract available
Editorial for "Development and Validation of Interpretable Machine Learning
Models for Clinically Significant Prostate Cancer Diagnosis in Patients With
Lesions of PI-RADS v2.1 Score >/=3".
J Magn Reson Imaging. 2024 Feb 29. doi: 10.1002/jmri.29277.
PubMed
The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of (223)Ra Therapy in
Metastatic Castration-Resistant Prostate Cancer Patients.
J Nucl Med. 2024 Feb 29:jnumed.123.266654. doi: 10.2967/jnumed.123.266654.
PubMed
Abstract available
First-in-Human (212)Pb-PSMA-Targeted alpha-Therapy SPECT/CT Imaging in a Patient with
Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med. 2024 Feb 29:jnumed.123.267189. doi: 10.2967/jnumed.123.267189.
PubMed
Development and Preclinical Evaluation of [(211)At]PSAt-3-Ga: An Inhibitor for
Targeted alpha-Therapy of Prostate Cancer.
J Nucl Med. 2024 Feb 29:jnumed.123.267043. doi: 10.2967/jnumed.123.267043.
PubMed
Abstract available
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment
Delivery for Non-metastatic Biochemical Recurrence After Primary Radical
Prostatectomy.
J Urol. 2024 Feb 14:101097JU0000000000003891. doi: 10.1097/JU.0000000000003891.
PubMed
Abstract available
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage
Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and
Oligometastasis, and Future Directions.
J Urol. 2024 Feb 14:101097JU0000000000003890. doi: 10.1097/JU.0000000000003890.
PubMed
Abstract available
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction
and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence
after Radical Prostatectomy.
J Urol. 2024 Feb 19:101097JU0000000000003892. doi: 10.1097/JU.0000000000003892.
PubMed
Abstract available
(68)Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical
recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging
trial.
Lancet Oncol. 2024 Feb 26:S1470-2045(24)00069.
PubMed
Abstract available
Autophagy and oxidative stress modulation mediate Bortezomib resistance in
prostate cancer.
PLoS One. 2024;19:e0289904.
PubMed
Abstract available
Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in
Prostate Cancer Cells after Androgen Deprivation Therapy.
PLoS One. 2024;19:e0299822.
PubMed
Distribution of neurovascular structures within the prostate gland and their
relationship to complications after radical prostatectomy.
Prostate. 2024;84:491-501.
PubMed
Abstract available
Testosterone bounce predicts favorable prognoses for prostate cancer patients
treated with degarelix.
Prostate. 2024 Feb 27. doi: 10.1002/pros.24679.
PubMed
Abstract available
Carboplatin in metastatic castration-resistant prostate cancer patients with
molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II
trial.
Ther Adv Urol. 2024;16:17562872241229876.
PubMed
Abstract available
Racial disparities in diagnosis and treatment of depression Associated with
androgen deprivation therapy for prostate cancer.
Urology. 2024 Feb 21:S0090-4295(24)00094-3. doi: 10.1016/j.urology.2024.
PubMed
Abstract available
Editorial Commentary on Improving Racial Disparities in Prostate Cancer.
Urology. 2024 Feb 21:S0090-4295(24)00095-5. doi: 10.1016/j.urology.2024.
PubMed
(18)Fluorine prostate-specific membrane antigen 1007 positron emission tomography
for high-risk prostate cancer.
Urology. 2024 Feb 27:S0090-4295(24)00131-6. doi: 10.1016/j.urology.2024.
PubMed
Thank you for your interest in scientific medicine.